Please try another search
MIZUHO MEDY CO., LTD. is a Japan-based company principally engaged in-vitro diagnostic pharmaceuticals business. The Company mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
Name | Age | Since | Title |
---|---|---|---|
Fuminari Karakawa | - | - | Chairman of the Board & President |
Hiroshi Sasaki | - | - | GM of Accounting Department & General Affairs Department and Director |
Nobuhiko Shigemi | 54 | 2011 | External Auditor |
Kenji Narahara | 61 | 2013 | Manager of Development Department and Director |
Kazuhiro Ichimaru | 64 | 2011 | Manager of Intellectual Property Department & Director |
Hirotaka Kawasaki | 65 | 2019 | Chairman of Board of Corporate Auditors |
Toshio Kamihara | 60 | 2015 | General Manager of Sales Division & Overseas Business Department and Director |
Takakichi Hashimoto | 68 | 2015 | External Auditor |
Tadashi Imamura | 65 | 2010 | MD, Technology Supervisor, Development Planning Manager & Director |
Katsumi Sasaki | 79 | 2015 | Independent External Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review